Glucosamine Market, by Product Type (Powder, Tablets , Capsules, and Liquid), by Application (Rheumatoid Arthritis, Asthma, Inflammatory Bowel Disease, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Dec 2020

Code : CMI4345

Pages :160

Formats :

Excel and PDF

Industry : Pharmaceutical

Glucosamine MarketSize and Trends

The global glucosamine market is estimated to be valued at US$ 763.7 million in 2020 and is expected to exhibit a CAGR of 5.20% during the forecast period (2020-2027).

Figure 1. Global Glucosamine Market Value (US$ Mn), 2016-2027

The increasing prevalence of rheumatoid arthritis is expected to propel growth of the global glucosamine market during the forecast period. For instance, according to the US National Library of Medicine’s report published in 2017, prevalence of rheumatoid arthritis across the globe was 43.3 % in 2017.

Furthermore, key players are focusing on launch and approval of product which is expected to propel growth of the global glucosamine market during the forecast period. For instance, in 2016, TSI Group Co. Ltd. (TSI) launched GlucosaGreenDF, a novel non-shellfish glucosamine branded product line produced by a patent-pending direct fermentation technology, in compliance with international monographs such as USP and the European Pharmacopeia.

Figure 2. Global Glucosamine Market Share (%), By Region, 2020

North America is expected to hold dominant position in the global glucosamine market during the forecast period owing to research and development activities in the field of glucosamine. For instance, in August 2018, Carlson Lab launched a novel formulation of Carlson Glucosamine & Chondroitin with Methyl SulfonylMethane (MSM), which provides human bone nourishing nutrients in one supplement.